Allogeneic bone marrow-derived cell therapy（Barts & The London Nhs Trust）

同种异体骨髓细胞疗法（Barts & The London Nhs Trust）

Report date: 2023/02/07 20:00:24

Base Information

Drug NameAllogeneic bone marrow-derived cell therapy（Barts & The London Nhs Trust）

Drug Alias NameBone marrow aspiration and intracoronary infusion of autologous bone marrow-derived cells（Barts & The London Nhs Trust）

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAngina Pectoris

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBarts & The London Nhs Trust

China Registration ClassN/A

Develop Information

Active CompaniesBarts & The London Nhs Trust

Inactive CompaniesN/A

Active IndicationsAngina Pectoris

Inactive IndicationsN/A

Other Information

ATC CodeN/A